Similar articles

• Exposure to anticholinergic and sedative drugs, risk of falls, and mortality: an elderly inpatient, multicenter cohort.

  Dauphinot V, Faure R, Omrani S, Goutelle S, Bourguignon L, Krolak-Salmon P, Mouchoux C. Dauphinot V, et al. J Clin Psychopharmacol. 2014 Oct;34(5):565-70. doi: 10.1097/JCP.0000000000000195. J Clin Psychopharmacol. 2014. PMID: 25133790
• Exposure to anticholinergic and sedative medicines as indicators of high-risk prescriptions in the elderly.

  Jean-Bart E, Moutet C, Dauphinot V, Krolak-Salmon P, Mouchoux C. Jean-Bart E, et al. Int J Clin Pharm. 2017 Dec;39(6):1237-1247. doi: 10.1007/s11096-017-0533-4. Epub 2017 Oct 31. Int J Clin Pharm. 2017. PMID: 29086145
• Factors associated with changes in exposure to anticholinergic and sedative medications in elderly hospitalized patients: multicentre longitudinal study.

  Dauphinot V, Faure R, Bourguignon L, Goutelle S, Krolak-Salmon P, Mouchoux C. Dauphinot V, et al. Eur J Neurol. 2017 Mar;24(3):483-490. doi: 10.1111/ene.13228. Epub 2016 Dec 27. Eur J Neurol. 2017. PMID: 28026898
• Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis.

  Ruxton K, Woodman RJ, Mangoni AA. Ruxton K, et al. Br J Clin Pharmacol. 2015 Aug;80(2):209-20. doi: 10.1111/bcp.12617. Epub 2015 May 20. Br J Clin Pharmacol. 2015. PMID: 25735839 Free PMC article.
• Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence.

  Collamati A, Martone AM, Poscia A, Brandi V, Celi M, Marzetti E, Cherubini A, Landi F. Collamati A, et al. Aging Clin Exp Res. 2016 Feb;28(1):25-35. doi: 10.1007/s40520-015-0359-7. Epub 2015 May 1. Aging Clin Exp Res. 2016. PMID: 25930085 Review.